Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $1.7 billion.

  • Conmed's Non-Current Assets fell 80.13% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.6 billion, marking a year-over-year decrease of 50.51%. This contributed to the annual value of $1.7 billion for FY2025, which is 80.13% down from last year.
  • Per Conmed's latest filing, its Non-Current Assets stood at $1.7 billion for Q4 2025, which was down 80.13% from $1.7 billion recorded in Q3 2025.
  • Conmed's 5-year Non-Current Assets high stood at $1.7 billion for Q3 2022, and its period low was $1.3 billion during Q1 2022.
  • In the last 5 years, Conmed's Non-Current Assets had a median value of $1.7 billion in 2024 and averaged $1.6 billion.
  • In the last 5 years, Conmed's Non-Current Assets skyrocketed by 3180.21% in 2023 and then crashed by 266.03% in 2024.
  • Over the past 5 years, Conmed's Non-Current Assets (Quarter) stood at $1.3 billion in 2021, then skyrocketed by 31.43% to $1.7 billion in 2022, then decreased by 1.86% to $1.7 billion in 2023, then dropped by 1.08% to $1.7 billion in 2024, then fell by 0.8% to $1.7 billion in 2025.
  • Its Non-Current Assets stands at $1.7 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $1.7 billion for Q2 2025.